TherapeuticsMD Inc

NASDAQ:TXMD  
0.47
-0.03 (-6.14%)
Earnings Announcements

TherapeuticsMD Announces Third Quarter 2021 Financial Results

Published: 11/11/2021 11:58 GMT
TherapeuticsMD Inc (TXMD) - Therapeuticsmd Announces Third Quarter 2021 Financial Results.
Therapeuticsmd Inc - Qtrly Total Net Revenue $25.41 Million Versus $19.34 Million.
Therapeuticsmd Inc - Qtrly Loss per Common Share, Basic and Diluted $0.11.
Therapeuticsmd Inc - Announced Significant Cost Savings Initiative Designed to Reduce Annual Costs in 2022 by at Least $40 Million.
Revenue is expected to be $28.85 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $28.8 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.